Representation of Multi‐Target Activity Landscapes Through Target Pair‐Based Compound Encoding in Self‐Organizing Maps

Activity landscape representations provide access to structure‐activity relationships information in compound data sets. In general, activity landscape models integrate molecular similarity relationships with biological activity data. Typically, activity against a single target is monitored. However, for steadily increasing numbers of compounds, activity against multiple targets is reported, resulting in an opportunity, and often a need, to explore multi‐target structure‐activity relationships. It would be attractive to utilize activity landscape representations to aid in this process, but the design of activity landscapes for multiple targets is a complicated task. Only recently has a first multi‐target landscape model been introduced, consisting of an annotated compound network focused on the systematic detection of activity cliffs. Herein, we report a conceptually different multi‐target activity landscape design that is based on a 2D projection of chemical reference space using self‐organizing maps and encodes compounds as arrays of pair‐wise target activity relationships. In this context, we introduce the concept of discontinuity in multi‐target activity space. The well‐ordered activity landscape model highlights centers of discontinuity in activity space and is straightforward to interpret. It has been applied to analyze compound data sets with three, four, and five target annotations and identify multi‐target structure‐activity relationships determinants in analog series.

[1]  José L. Medina-Franco,et al.  Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..

[2]  Anne Mai Wassermann,et al.  Design of Multitarget Activity Landscapes That Capture Hierarchical Activity Cliff Distributions , 2011, J. Chem. Inf. Model..

[3]  J. Bajorath Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.

[4]  Jürgen Bajorath,et al.  Comprehensive Analysis of Single‐ and Multi‐Target Activity Cliffs Formed by Currently Available Bioactive Compounds , 2011, Chemical biology & drug design.

[5]  J. Mestres,et al.  Conciliating binding efficiency and polypharmacology. , 2009, Trends in pharmacological sciences.

[6]  J. Bajorath,et al.  Activity landscape representations for structure-activity relationship analysis. , 2010, Journal of medicinal chemistry.

[7]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[8]  Rajarshi Guha,et al.  Structure-Activity Landscape Index: Identifying and Quantifying Activity Cliffs , 2008, J. Chem. Inf. Model..

[9]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[10]  Jürgen Bajorath,et al.  Rationalizing Three-Dimensional Activity Landscapes and the Influence of Molecular Representations on Landscape Topology and the Formation of Activity Cliffs , 2010, J. Chem. Inf. Model..

[11]  Mathias Wawer,et al.  Navigating structure-activity landscapes. , 2009, Drug discovery today.

[12]  Jürgen Bajorath,et al.  From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds , 2009, ChemMedChem.

[13]  Anne Mai Wassermann,et al.  Computational Analysis of Multi‐target Structure–Activity Relationships to Derive Preference Orders for Chemical Modifications toward Target Selectivity , 2010, ChemMedChem.

[14]  Wendy A. Warr,et al.  ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI) , 2009, J. Comput. Aided Mol. Des..

[15]  Johann Gasteiger,et al.  Neural networks in chemistry and drug design , 1999 .

[16]  Jürgen Bajorath,et al.  Design of multi-target activity landscapes that capture hierarchical activity cliff distributions , 2012, Journal of Cheminformatics.

[17]  J. Bajorath,et al.  Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices. , 2008, Journal of medicinal chemistry.

[18]  Michael J. Keiser,et al.  The Chemical Basis of Pharmacology , 2010, Biochemistry.

[19]  John P. Overington ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr. , 2009, Journal of computer-aided molecular design.

[20]  José L. Medina-Franco,et al.  Structure–activity relationships of benzimidazole derivatives as antiparasitic agents: Dual activity-difference (DAD) maps , 2011 .

[21]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.